catalyst

Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Sym — primary completion

as of 2026-07-01
at a glance
2024-01-25 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Sym — primary completion
Type
Trial Readout
Date
2024-01-25
Date type
ACTUAL
Phase
Phase 3
This event happened.